COVID-19: Diagnosis, Management and Response

Mhaske, Ashwini Shalikrao and Chakole, Swaroopa (2021) COVID-19: Diagnosis, Management and Response. Journal of Pharmaceutical Research International, 33 (40B). pp. 161-170. ISSN 2456-9119

[thumbnail of 3088-Article Text-4822-1-10-20221006.pdf] Text
3088-Article Text-4822-1-10-20221006.pdf - Published Version

Download (290kB)

Abstract

Background: COVID infection 2019 (COVID-19) is identified as a disease caused by Corona virus formally known as severe acute respiratory syndrome (SARS-CoV-2), which was first detected in Wuhan City, Hubei Province, China, amidst of an outbreak of respiratory sickness cases.

Summary: As there is no affirmed total course of treatment for the Novel Coronavirus, the best way to handle it is by playing it safe, its administration and early reaction. Segregation and disinfection go inseparably with regards to dealing with a COVID positive patient. In any case, the predetermined number of clinical office accessible is blocking the cycle of control and anticipation for a particularly number of infected patients.

Conclusion: As the pandemic is advancing, more examinations and exploration is needed to effectively deal with the spread of the novel Corona virus. Foundation improvement and arrangement of clinical office and gear is the preeminent prerequisite for early reaction and treatment.

Item Type: Article
Subjects: Opene Prints > Medical Science
Depositing User: Managing Editor
Date Deposited: 04 Mar 2023 07:36
Last Modified: 30 Mar 2024 03:48
URI: http://geographical.go2journals.com/id/eprint/1397

Actions (login required)

View Item
View Item